Indivior Pharmaceuticals, Inc.: common-stock repurchase payments

What this measure means

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Exact concept: us-gaap:PaymentsForRepurchaseOfCommonStock. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2022-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• Indivior Pharmaceuticals, Inc.: total assets
• Indivior Pharmaceuticals, Inc.: total liabilities
• Indivior Pharmaceuticals, Inc.: stockholders equity
• Indivior Pharmaceuticals, Inc.: cash and cash equivalents
• Indivior Pharmaceuticals, Inc.: net income or loss
• Indivior Pharmaceuticals, Inc.: operating cash flow
• Indivior Pharmaceuticals, Inc.: capital expenditure payments
• Indivior Pharmaceuticals, Inc.: contract revenue excluding tax
• Indivior Pharmaceuticals, Inc.: financing cash flow
• Indivior Pharmaceuticals, Inc.: investing cash flow
• Indivior Pharmaceuticals, Inc.: retained earnings or deficit
• Indivior Pharmaceuticals, Inc.: basic weighted-average shares
• Indivior Pharmaceuticals, Inc.: diluted weighted-average shares
• Indivior Pharmaceuticals, Inc.: basic earnings per share
• Indivior Pharmaceuticals, Inc.: diluted earnings per share
• Indivior Pharmaceuticals, Inc.: income tax expense or benefit
• Indivior Pharmaceuticals, Inc.: net property, plant and equipment
• Indivior Pharmaceuticals, Inc.: share-based compensation expense
• Indivior Pharmaceuticals, Inc.: operating income or loss
• Indivior Pharmaceuticals, Inc.: current assets
• Indivior Pharmaceuticals, Inc.: current liabilities
• Indivior Pharmaceuticals, Inc.: current accounts payable
• Indivior Pharmaceuticals, Inc.: goodwill carrying amount
• Indivior Pharmaceuticals, Inc.: net current accounts receivable
• Indivior Pharmaceuticals, Inc.: operating expenses
• Indivior Pharmaceuticals, Inc.: net inventory
• Indivior Pharmaceuticals, Inc.: gross profit
• Indivior Pharmaceuticals, Inc.: selling, general and administrative expense

Inspect the source

Entity

Indivior Pharmaceuticals, Inc. / CIK 0001625297

Captured

2026-09-21T17:22:01.013Z

SEC response SHA-256

624f228e5872dd6744664c7b0cb0d609339e94001927139882e8e7b85e1c1b6c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001625297.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))